Cognison
Cognision is a neurotechnology company advancing brain-based biomarkers for clinical research and drug development. Through its FDA-cleared COGNISION® platform, the company provides objective, sensitive, and reliable measures of cognitive function using quantitative EEG (qEEG) and event-related potential (ERP) technologies. Designed for use across clinical trials and cognitive research, Cognision helps pharmaceutical and biotechnology organizations evaluate treatment effects, identify patient subgroups, and accelerate the development of therapies for neurological and neuropsychiatric disorders. With scalable, easy-to-implement assessments and deep expertise in brain health, Cognision delivers actionable insights that support more informed decision-making throughout the research and development process.
